docetaxel anhydrous has been researched along with mevalonic acid in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (mevalonic acid) | Trials (mevalonic acid) | Recent Studies (post-2010) (mevalonic acid) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 3,810 | 33 | 922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelmann, U; Epplen, R; Heidenreich, A; Ohlmann, CH; Stöckle, M | 1 |
| Bertucci, F; Birnbaum, D; Cabaud, O; Cervera, N; Charafe-Jauffret, E; Finetti, P; Ginestier, C; Guille, A; Josselin, E; Larderet, G; Monville, F; Sebti, S; Viens, P; Wicinski, J | 1 |
2 other study(ies) available for docetaxel anhydrous and mevalonic acid
| Article | Year |
|---|---|
Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Diphosphonates; Docetaxel; Drug Synergism; Farnesol; Humans; Ibandronic Acid; Male; Mevalonic Acid; Prenylation; Prostatic Neoplasms; Signal Transduction; Taxoids | 2011 |
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Docetaxel; Female; Gene Expression Profiling; Humans; Mevalonic Acid; Mice; Mice, SCID; Neoplasms, Basal Cell; Neoplastic Stem Cells; Taxoids | 2012 |